Liberum Capital announced Genus PLC (LON:GNS), upholding its stock price target at 1,950.00GBX today
- Updated: October 2, 2016
In a report released on 10/3/2016 Liberum Capital hold steady the stock price target of Genus PLC (LON:GNS) from 1,950.00GBX to 1,950.00GBX reporting a possible downside of -0.02%.
Previously on Monday September 26, 2016, Liberum Capital released a statement about Genus PLC (LON:GNS) held steady the target price at 1,950.00GBX. At the time, this indicated a possible upside of 0.01%.
Just yesterday Genus PLC (LON:GNS) traded 1.39% higher at 1,988.50GBX. Genus PLC’s 50-day moving average is 1,902.62GBX and its 200-day moving average is 1,674.21GBX. The last stock price is up 17.97% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 5,213 shares of GNS traded hands, down from an average trading volume of 64,047
Recent Performance Chart
Genus PLC has 52 week low of 1,281.00GBX and a 52 week high of 2,056.00GBX with a PE ratio of 24.60 and has a market capitalization of 0 GBX.
In addition to Liberum Capital reporting its stock price target, a total of 5 brokerages have issued a research note on the company. The average stock price target is 1,485.60GBX with 1 brokerage rating the stock a strong buy, 1 brokerage rating the stock a buy, 4 brokerages rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
Brief Synopsis On Genus PLC (LON:GNS)
Genus plc is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments are Genus PIC, Genus ABS and Genus Asia. The Genus PIC segment serves porcine customers in North America, Latin America and Europe. The Genus ABS segment serves dairy and beef customers in North America, Latin America and Europe. The Genus Asia segment serves porcine, dairy and beef customers in Asian markets. The Company breeds and distributes genes of pigs and bulls. In the porcine market, the Company sells genetically boars and sows that produce offspring with characteristics, such as growth or leaner meat. In the dairy and beef markets, the Company's primary product is bull semen, which is delivered through artificial insemination. The Company also offers genetically superior embryos through its subsidiary, In Vitro Brasil S.A.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.